Prostate Cancer | Specialty

The OncLive Prostate Cancer condition center page is a comprehensive resource for clinical news and expert insights on how to approach treatment for patients with nonmetastatic, castration-resistant, or castration-sensitive prostate cancer. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, ongoing research, and treatment advances with androgen receptor inhibitors, PARP inhibitors, and more in prostate cancer.

Dr. Gomella on Immunotherapy Developments in Prostate Cancer

March 19th 2018

Leonard Gomella, MD, professor, chair, Department of Urology, director, Sidney Kimmel Cancer Center Network, Thomas Jefferson University Hospital, discusses immunotherapy developments for patients with prostate cancer.

Dr. Mann on Immunotherapy Developments in Prostate Cancer

March 19th 2018

Mark J. Mann, MD, assistant professor, Sidney Kimmel Cancer Center, Thomas Jefferson Hospital, discusses the future of immunotherapy in prostate cancer.

Expert Makes Case for Hypofractionation in Prostate Cancer

March 19th 2018

Howard M. Sandler, MD, discusses the emergence of hypofractionation as a viable treatment approach for patients with prostate cancer.

Dr. Mason on Next Steps Following 10-Year PROTECT Study Data in Prostate Cancer

March 15th 2018

Malcolm Mason, MD, Cancer Research Wales Professor of Clinical Oncology at Cardiff University, discusses next steps following the 10-year PROTECT study data for patients with prostate cancer.

Expert Emphasizes Healthy Lifestyle in Prostate Cancer Care

March 15th 2018

Stephen J. Freedland, MD, shares his insight on how to counsel patients with prostate cancer on the benefits of leading a healthier life.

Expert Discusses Optimizing HIFU and Other Strategies in Prostate Cancer

March 14th 2018

Timothy J. Daskivich, MD, discusses the use of High-intensity focused ultrasound and other treatment strategies in the prostate cancer armamentarium.

Dr. Slovin on the Promise of GnRH Antagonists in Prostate Cancer

March 13th 2018

Susan F. Slovin, MD, PhD, a medical oncologist at Memorial Sloan Kettering Cancer Center, discusses the promise of GnRH antagonists in prostate cancer.

Managing Advanced Prostate Cancer in the Future

March 13th 2018

Hereditary Prostate Cancer Testing in Practice

March 13th 2018

Improvements in Detecting and Treating Metastatic CRPC

March 13th 2018

Utilizing AR-Targeted Therapies in CRPC

March 13th 2018

Assessing Treatment Response in M0 CRPC

March 13th 2018

Other Emerging Combination Approaches in RCC

March 13th 2018

AR-Targeted Therapies in CRPC

March 13th 2018

Treatment Goals in M0 CRPC

March 13th 2018

CRPC: Goals of Imaging for the Detection of Metastasis

March 13th 2018

Guidelines for Early Detection of Metastasis in CRPC

March 13th 2018

Treatment Challenges in Nonmetastatic CRPC

March 13th 2018

Detecting Newly Diagnosed Metastatic Prostate Cancer

March 13th 2018

Sequencing Therapy With ADT Combinations

March 13th 2018